Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04246281 · ClinicalTrials.gov registry record · NA

The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain

A NA study of Low Back Pain and Back Pain, sponsored by SPR Therapeutics.

Active
Registry status
NA
Development phase
230
Enrollment target
18
Study locations

NCT04246281: Active NA study of Low Back Pain and Back Pain, sponsored by SPR Therapeutics.

NCT04246281 is a NA study of Low Back Pain and Back Pain that is active but no longer recruiting, run by SPR Therapeutics. The registered enrollment target is 230 participants, below the 502-participant average among 122 other Low Back Pain trials with a reported enrollment target (54% lower). The trial reports 18 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04246281, a NA study of Low Back Pain and Back Pain, is active but no longer recruiting, sponsored by SPR Therapeutics.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
230 participants
Enrollment target
18
Study locations

Study Summary

The purpose of this study is to compare standard of care treatments for back pain to electrical stimulation. Stimulation is delivering small amounts of electricity to the nerves in your low back. This study will use a device called the SPRINT Peripheral Nerve Stimulation (PNS) System. The device is cleared by the FDA for up to 60 days of use for the relief of chronic or acute pain (including back pain)

Primary Outcome

Average pain is measured using question 5 from the Brief Pain Inventory- Short Form (BPI-5). BPI-5 is a scale of 0 to 10 where 0 represents no pain and 10 represents worst pain.

Conditions Studied

Interventions

  • DEVICE SPRINT Peripheral Nerve Stimulation (PNS) System
  • PROCEDURE Standard interventional management of low back pain

Study Locations (18)

North Carolina

  • Duke University - Durham
  • Center for Clinical Research - Winston-Salem

Virginia

  • Virginia iSpine Physicians - Richmond
  • Hunter Holmes McGuire Veterans Affairs Medical Center - Richmond

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

California

  • IPM Medical Group - Walnut Creek

Colorado

  • Denver Back Pain Specialists - Greenwood Village

District of Columbia

  • International Spine, Pain & Performance Center - Washington D.C.

Georgia

  • Emory University - Atlanta

Idaho

  • Northwest Speciality Hospital - Post Falls

Trial Details

FieldValue
Enrollment Target 230 participants
Start Date 2020-06-17
Est. Completion 2027-04
Phase NA
SPR Therapeutics

10 total trials

What the registry record for NCT04246281 still lists

NCT04246281 is an interventional study that assigns participants to a tested intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap, below the 502-participant average among 122 other Low Back Pain trials with a reported enrollment target (54% lower).

The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which SPRINT Peripheral Nerve Stimulation (PNS) System is the first listed.

NCT04246281 lists 18 locations in 16 states (North Carolina, Virginia, Arkansas).

Frequently Asked Questions

What is clinical trial NCT04246281 about?

NCT04246281 is a clinical study titled "The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain". The purpose of this study is to compare standard of care treatments for back pain to electrical stimulation. Stimulation is delivering small amounts of electricity to the nerves in your low back. This study will use a device called the SPRINT Peripheral Nerve Stimulation (PNS) System. The device is ...

What is the current status of trial NCT04246281?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 230 participants. The study started on 2020-06-17. Estimated completion is 2027-04.

What conditions does trial NCT04246281 study?

This clinical trial studies the following conditions: Low Back Pain, Back Pain.

What interventions are being tested in trial NCT04246281?

The interventions under investigation include: SPRINT Peripheral Nerve Stimulation (PNS) System (DEVICE), Standard interventional management of low back pain (PROCEDURE).

Who is sponsoring clinical trial NCT04246281?

This trial is sponsored by SPR Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04246281 being conducted?

This trial has 18 study locations across Arkansas, California, Colorado, District of Columbia, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04246281's enrollment target sits among peer trials

230 27th of 122 higher than 96 of 122 other Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02710253 · 230 participants · Phase 2

    Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy

  • NCT02777879 · 230 participants

    Lung Microbiome and Inflammation in Early COPD

  • NCT03824483 · 230 participants · Phase 2

    Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  • NCT03833622 · 230 participants · NA

    Shared Decision Making to Improve Goals of Care in the ED

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04246281, the US trial registry maintained by the National Library of Medicine. NCT04246281 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.